ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000223759.2	ABT-263 (navitoclax)	Brain lower grade glioma	0.024077874	Resistant
ENSG00000223759.2	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.000664794	Resistant